Assiut governorate
Asyut, 715715, Egypt
NCT Number: NCT06121037
Combined migraine and cervicogenic headache present significant challenges in clinical management due to their complex and overlapping pathophysiologies. Both conditions involve the trigeminocervical complex, suggesting a potential shared anatomical and neurobiological basis
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Asyut, 715715, Egypt
Traditional treatment approaches for these headaches often include pharmacological interventions, but in cases of refractory or inadequate response, interventional techniques targeting the greater occipital nerve (GON) have gained attention.
Radiofrequency ablation (RFA) has gained recognition as a potential therapeutic option for patients with refractory combined migraine and cervicogenic headaches. The proximal and distal ultrasound-guided approaches are widely utilized for GON RFA. These approaches aim to disrupt pain signals transmitted by the GON and provide relief of pain for these headache disorders
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
proximal GON radiofrequency
distal GON radiofrequency
Time frame: baseline and at follow-up visits (2 weeks.1, 2.3, and 6 months)
0-10 scale, with 0 indicating no pain and 10 indicating the worst possible pain.
Assiut University
Other
Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach): Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06764433
Brain Diseases, Central Nervous System Diseases
Ankara, Cankaya, Turkey (Türkiye)
View Trial DetailsNCT07088562
Bursitis, Capsulitis, Adhesive
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06710704
Arm Injuries, Corticosteroids Injections
Tanta, ElGharbia, Egypt
View Trial DetailsNCT06710782
Arthritis, Chronic Pain
Tanta, ElGharbia, Egypt
View Trial Details